These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9338101

  • 21. Wild-type TP53 inhibits G(2)-phase checkpoint abrogation and radiosensitization induced by PD0166285, a WEE1 kinase inhibitor.
    Li J, Wang Y, Sun Y, Lawrence TS.
    Radiat Res; 2002 Mar; 157(3):322-30. PubMed ID: 11839095
    [Abstract] [Full Text] [Related]

  • 22. Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.
    Kaufmann WK, Nevis KR, Qu P, Ibrahim JG, Zhou T, Zhou Y, Simpson DA, Helms-Deaton J, Cordeiro-Stone M, Moore DT, Thomas NE, Hao H, Liu Z, Shields JM, Scott GA, Sharpless NE.
    J Invest Dermatol; 2008 Jan; 128(1):175-87. PubMed ID: 17597816
    [Abstract] [Full Text] [Related]

  • 23. A UVR-induced G2-phase checkpoint response to ssDNA gaps produced by replication fork bypass of unrepaired lesions is defective in melanoma.
    Wigan M, Pinder A, Giles N, Pavey S, Burgess A, Wong S, Sturm RA, Gabrielli B.
    J Invest Dermatol; 2012 Jun; 132(6):1681-8. PubMed ID: 22402442
    [Abstract] [Full Text] [Related]

  • 24. Antisense inhibition of CAS, the human homologue of the yeast chromosome segregation gene CSE1, interferes with mitosis in HeLa cells.
    Ogryzko VV, Brinkmann E, Howard BH, Pastan I, Brinkmann U.
    Biochemistry; 1997 Aug 05; 36(31):9493-500. PubMed ID: 9235994
    [Abstract] [Full Text] [Related]

  • 25. Maintaining genetic stability through TP53 mediated checkpoint control.
    Wahl GM, Linke SP, Paulson TG, Huang LC.
    Cancer Surv; 1997 Aug 05; 29():183-219. PubMed ID: 9338102
    [Abstract] [Full Text] [Related]

  • 26. Cytotoxicity mechanisms of pyrazino[1,2-b]isoquinoline-4-ones and SAR studies.
    Ortín I, González JF, Cuesta Ede L, Manguan-García C, Perona R, Avendaño C.
    Bioorg Med Chem; 2009 Dec 01; 17(23):8040-7. PubMed ID: 19875300
    [Abstract] [Full Text] [Related]

  • 27. A comprehensive complex systems approach to the study and analysis of mammalian cell cycle control system in the presence of DNA damage stress.
    Abroudi A, Samarasinghe S, Kulasiri D.
    J Theor Biol; 2017 Sep 21; 429():204-228. PubMed ID: 28647496
    [Abstract] [Full Text] [Related]

  • 28. Robustness of G1/S checkpoint pathways in cell cycle regulation based on probability of DNA-damaged cells passing as healthy cells.
    Ling H, Kulasiri D, Samarasinghe S.
    Biosystems; 2010 Sep 21; 101(3):213-21. PubMed ID: 20654685
    [Abstract] [Full Text] [Related]

  • 29. p53 prevents immature escaping from cell cycle G2 checkpoint arrest through inhibiting cdk2-dependent NF-Y phosphorylation.
    Yun UJ, Park HD, Shin DY.
    Cancer Res Treat; 2006 Dec 21; 38(4):224-8. PubMed ID: 19771247
    [Abstract] [Full Text] [Related]

  • 30. DNA damage checkpoints: implications for cancer therapy.
    O'Connor PM, Fan S.
    Prog Cell Cycle Res; 1996 Dec 21; 2():165-73. PubMed ID: 9552393
    [Abstract] [Full Text] [Related]

  • 31. Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.
    Pietenpol JA, Stewart ZA.
    Toxicology; 2002 Dec 27; 181-182():475-81. PubMed ID: 12505356
    [Abstract] [Full Text] [Related]

  • 32. The role of protein kinase C in G1 and G2/M phases of the cell cycle (review).
    Fishman DD, Segal S, Livneh E.
    Int J Oncol; 1998 Jan 27; 12(1):181-6. PubMed ID: 9454903
    [Abstract] [Full Text] [Related]

  • 33. E2F4 function in G2: maintaining G2-arrest to prevent mitotic entry with damaged DNA.
    Plesca D, Crosby ME, Gupta D, Almasan A.
    Cell Cycle; 2007 May 15; 6(10):1147-52. PubMed ID: 17507799
    [Abstract] [Full Text] [Related]

  • 34. Control of the G2/M transition.
    Stark GR, Taylor WR.
    Mol Biotechnol; 2006 Mar 15; 32(3):227-48. PubMed ID: 16632889
    [Abstract] [Full Text] [Related]

  • 35. Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective.
    Murnane JP.
    Cancer Metastasis Rev; 1995 Mar 15; 14(1):17-29. PubMed ID: 7606817
    [Abstract] [Full Text] [Related]

  • 36. Control of G1 arrest after DNA damage.
    Kastan MB, Kuerbitz SJ.
    Environ Health Perspect; 1993 Dec 15; 101 Suppl 5(Suppl 5):55-8. PubMed ID: 8013425
    [Abstract] [Full Text] [Related]

  • 37. Combining DNA damaging agents and checkpoint 1 inhibitors.
    Prudhomme M.
    Curr Med Chem Anticancer Agents; 2004 Sep 15; 4(5):435-8. PubMed ID: 15379699
    [Abstract] [Full Text] [Related]

  • 38. G2 checkpoint abrogators as anticancer drugs.
    Kawabe T.
    Mol Cancer Ther; 2004 Apr 15; 3(4):513-9. PubMed ID: 15078995
    [Abstract] [Full Text] [Related]

  • 39. Importance of TP53 and RB in the repair of potentially lethal damage and induction of color junctions after exposure to ionizing radiation.
    Franken NA, van Bree C, ten Cate R, van Oven CH, Haveman J.
    Radiat Res; 2002 Dec 15; 158(6):707-14. PubMed ID: 12452773
    [Abstract] [Full Text] [Related]

  • 40. Cell cycle checkpoints.
    Murray A.
    Curr Opin Cell Biol; 1994 Dec 15; 6(6):872-6. PubMed ID: 7880536
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.